Description
Tirzepatide 5mg – Dual Incretin Therapy for Type 2 Diabetes & Weight Management
Tirzepatide 5mg is a cutting-edge, once-weekly injectable medication developed to improve blood glucose control and support weight loss in adults with type 2 diabetes. It works by activating both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors—mimicking natural incretin hormones that play a key role in glucose metabolism and appetite regulation.
Key Benefits:
-
Lowers A1C and improves blood glucose stability
-
Reduces appetite and promotes sustained weight loss
-
Enhances insulin sensitivity and metabolic function
-
Convenient once-weekly subcutaneous injection
Usage:
Tirzepatide 5mg should be administered under the supervision of a licensed healthcare professional. It is typically used alongside diet and exercise as part of a comprehensive diabetes care plan.
Important Note:
Not intended for individuals with type 1 diabetes or those experiencing diabetic ketoacidosis. Always consult with your physician before initiating treatment.
⚠️ For Research Use Only. Not for Human Consumption.
This compound is sold strictly for in vitro laboratory research purposes only. It is not intended for human or veterinary use, nor for diagnostic or therapeutic purposes. No claims are made regarding safety or efficacy in any clinical application.Disclaimer:
All information provided is for educational and scientific reference only. Statements have not been evaluated by the FDA or any medical regulatory body. This product is not a drug or supplement. Buyer assumes all responsibility for lawful use and compliance with applicable regulations.Terms of Sale:
By purchasing from LIBERTY LABS, you confirm that you are a qualified researcher or institution equipped to handle this material safely. You accept full responsibility for its use and understand that Liberty Labs assumes no liability for misuse, misinterpretation, or improper application of this compound. ALL SALES FINAL